CLINICAL_TRIALS
research
· 2016-06-07
Clinical Trial Update: Feasibility Study of Intraperitoneal Paclitaxel [Phase 2]
Summary
Feasibility Phase 2 clinical trial evaluating intraperitoneal paclitaxel for gastric cancer; the current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National University Hospital, Singapore | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN